In re U.S. Healthcare, Inc. Securities Litigation

122 F.R.D. 467, 1988 WL 121451
CourtDistrict Court, E.D. Pennsylvania
DecidedJuly 15, 1988
DocketMaster File No. 88-0559
StatusPublished
Cited by3 cases

This text of 122 F.R.D. 467 (In re U.S. Healthcare, Inc. Securities Litigation) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re U.S. Healthcare, Inc. Securities Litigation, 122 F.R.D. 467, 1988 WL 121451 (E.D. Pa. 1988).

Opinion

MEMORANDUM OF DECISION

McGLYNN, District Judge.

I. INTRODUCTION

The plaintiffs, a class consisting of persons who purchased the stock of U.S. Healthcare, Inc. (“U.S. Healthcare”) during the period between July 3, 1985 and August 21, 1987, initiated six separate securities fraud actions which have been consolidated in one Amended Complaint filed on March 11, 1988. Plaintiffs’ allegations of fraud center on allegedly false and misleading estimates of unrealized medical claim expenses in the company’s annual reports and S.E.C. filings for the years 1985 and 1986. On August 21, 1987, the date upon which the class period closes, the company publicly announced its intention to increase its reserves for medical expenses, presumably to correct the previous underestimations. After August 21, the price of the company’s stock declined. Plaintiffs claim that the defendants, including Arthur [468]*468Young & Company (“Arthur Young”), the company’s certified public accountant, deliberately misstated the company’s financial condition during the class period in order to artificially inflate the price of U.S. Healthcare stock. Presently before the court is Arthur Young’s motion to dismiss for failure to plead fraud with particularity. Fed.R.Civ.P. 9(b). For the reasons that follow, the motion will be denied.

II. THE COMPLAINT AGAINST ARTHUR YOUNG

Plaintiffs’ action against Arthur Young centers on the firm’s certification of the company’s annual financial statements for the years 1985 and 1986,1 which were incorporated in the company’s annual reports for those years. Plaintiffs allege that Arthur Young

knew, should have known or recklessly disregarded the fact that the financial statements in U.S.H.’s Prospectus, 1985 and 1986 Annual Reports were false and misleading and thus substantially aided and abetted U.S.H. and the individual defendants in the dissemination of materially false and misleading information. Particularly, Arthur Young did not comply with the standards as provided for in GAAS by failing to exercise reasonable and professional care as set forth in greater detail in paragraphs 55 through 64.

Consolidated and Amended Class Action Complaint, ¶ 82. In paragraphs 58 through 64, plaintiffs identify specifically the accounting standards allegedly violated by Arthur Young in preparing the financial statements. The transgressions identified include Arthur Young’s alleged failure to follow a conservative approach in order to provide for early recognition of unfavorable events, failure to provide a complete picture of the company’s financial condition, failure to make a proper study of the company’s internal controls to determine whether reliance on figures provided by the company was justified, and failure to obtain sufficient evidentiary matter through investigation, observation, inquiries, and confirmations to afford a reasonable basis for an opinion regarding the financial statements under examination. As a result, plaintiffs allege that “[t]he representations in the Arthur Young audit opinions that the financial statements complied with GAAP and that its own examinations complied with GAAS, were material misrepresentations of fact, knowingly or recklessly made by Arthur Young.” Consolidated and Amended Class Action Complaint, 1163.

The financial statements at issue, according to plaintiffs, provided a materially false picture of the company’s profitability. This is so because, in underestimating the amount of reserves necessary to cover medical expenses, the company was able to show great profits during a period when the cost of medical care was increasing rapidly. These profits caused the price of the company’s stock to rise until the August, 1987 announcement that a large amount of these “profits” would be shifted on the balance sheet to cover the expenses that had previously been underestimated.

III. DISCUSSION

Rule 9(b) provides:

In all averments of fraud or mistake, the circumstances constituting fraud or mistake shall be stated with particularity. Malice, intent, knowledge, and other condition of mind of a person may be averred generally.

Fed.R.Civ.P. 9(b). The purpose of Rule 9(b), according to our Court of Appeals, is “to place the defendants on notice of the precise misconduct with which they are charged, and to safeguard defendants against spurious charges of immoral and fraudulent behavior.” Seville Industrial Machinery Corp. v. Southmost Machinery Corp., 742 F.2d 786, 791 (3d Cir.1984). The Rule requires, only that the “circumstances [469]*469constituting the fraud” be pleaded with particularity. Cramer v. General Tel. & Electronics Corp., 582 F.2d 259, 272 (3d Cir.), cert. denied, 439 U.S. 1129, 99 S.Ct. 1048, 59 L.Ed.2d 90 (1979). Conditions of mind such as knowledge and intent may be pleaded generally. Id. at 273. I approach the issue here mindful of the Third Circuit’s admonition that

[i]n applying the first sentence of Rule 9(b) courts must be sensitive to the fact that its application, prior to discovery, may permit sophisticated defrauders to successfully conceal the details of their fraud. Moreover, in applying the rule, focusing exclusively on its ‘particularity’ language ‘is too narrow an approach and fails to take account of the general simplicity and flexibility contemplated by the rules.’

Christidis v. First Pennsylvania Mortgage Trust, 717 F.2d 96, 99-100 (3d Cir.1983) (quoting 5 C. Wright & A. Miller, Federal practice and Procedure § 1298, at 407 (1969)).

Christidis involved allegations by a class of purchasers of shares of a mortgage trust that the defendants, including the accountant for the trust, had misrepresented the financial condition of the trust in their annual reports. The alleged misrepresentations, like those at issue here, involved estimates of expected future losses. The plaintiffs in Christidis alleged that the amount of income allocated to the reserve fund for future losses was inadequate and that the defendants knew or should have known that the figures had not been determined in conformance with the applicable accounting standards. Id. at 97-98. The court of appeals affirmed the district court’s dismissal of the Complaint pursuant to Rule 9(b) stating:

[the Complaint’s] defect is the complete absence of any disclosure of the manner in which, in establishing reserves for bad debts in the financial statements relied upon, the defendants knowingly departed from reasonable accounting practices. Those reserves were estimates or predictions of the likely collection or liquidation experience of the Trust in the future. They could be fraudulent only if, when they were established, the responsible parties knew or should have known that they were derived in a manner inconsistent with reasonable accounting practices. What those practices are and how they were departed from is nowhere set forth.

Id. at 99-100.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Ikon Office Solutions, Inc. Securities Litigation
66 F. Supp. 2d 622 (E.D. Pennsylvania, 1999)
Waslow v. Grant Thornton L.L.P. (In Re Greenberg)
212 B.R. 76 (E.D. Pennsylvania, 1997)
In Re Chambers Development Securities Litigation
848 F. Supp. 602 (W.D. Pennsylvania, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
122 F.R.D. 467, 1988 WL 121451, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-us-healthcare-inc-securities-litigation-paed-1988.